Bruce N. Jacobs Kymera Therapeutics, Inc. (KYMR) insider trading activity
Bruce N. Jacobs is Chief Financial Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 168,554 shares of KYMR, which is worth approximately $7.85 Million. The most recent transaction as insider was on Mar 08, 2021, when has been sold 10,000 shares (Common Stock) at a price of $51.3 per share, resulting in proceeds of $513,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
169K
18.41%
3M change
46.52%
12M change
Total Value Held
$7.85 Million
Bruce N. Jacobs Transaction History
BNJ
Bruce N. Jacobs
Chief Financial Officer
Watertown, MA